<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">249</article-id><article-id pub-id-type="doi">10.25208/0042-4609-2016-92-3-123-127</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DRUG TREATMENT IN DERMATOVENEROLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ФАРМАКОТЕРАПИЯ В ДЕРМАТОВЕНЕРОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The experiment of using loratadinum in pregnant women with pruritic dermatoses</article-title><trans-title-group xml:lang="ru"><trans-title>Опыт применения лоратадина у беременных с зудящими дерматозами</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Monakhov</surname><given-names>K. N.</given-names></name><name xml:lang="ru"><surname>Монахов</surname><given-names>К. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kholodilova</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Холодилова</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>cholnatalex23@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">First Pavlov State Medical University of St. Petersburg</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО «Первый Санкт-Петербургский государственный медицинский университет им. академика И.П. Павлова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-06-24" publication-format="electronic"><day>24</day><month>06</month><year>2016</year></pub-date><volume>92</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>123</fpage><lpage>127</lpage><history><date date-type="received" iso-8601-date="2017-08-24"><day>24</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, Monakhov K.N., Kholodilova N.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, Монахов К.Н., Холодилова Н.А.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">Monakhov K.N., Kholodilova N.A.</copyright-holder><copyright-holder xml:lang="ru">Монахов К.Н., Холодилова Н.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/249">https://vestnikdv.ru/jour/article/view/249</self-uri><abstract xml:lang="en"><p>Results of examination of 64 pregnant women with allergic dermatosis. Provides results of the efficacy, tolerance and safety study of the loratadinum drug in pregnant women with allergic dermatosis.</p></abstract><trans-abstract xml:lang="ru"><p>Представлены результаты обследования 64 беременных женщин, страдающих аллергодерматозами. Приведены результаты исследования эффективности, переносимости и безопасности применения препарата лоратадин у беременных женщин, больных аллергодерматозами.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>аллергодерматозы</kwd><kwd>беременность</kwd><kwd>препарат лоратадин</kwd><kwd>антигистаминные средства</kwd><kwd>allergic dermatosis</kwd><kwd>pregnancy</kwd><kwd>loratadinum drug</kwd><kwd>antihistamines</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Pawankar R., Canonica G.W., Holgate S.T. et al. The World Allergy Orgamization White Book on Allergy (Update). 2013.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Päunescu M.M., Feier V., Päunescu M. et al. Dermatoses of pregnancy. Acta Dermatovenerol Alp Panonica Adriat 2008; 17 (1): 4-11.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Kemmett D. The influence of menstrual cycle and pregnancy on atopic dermatitis. D. Kemmett, M.J. Tidman. Br J Dermatol 1991; 125 (1): 59-61.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Vaughan Jones S.A., Hern S., Nelson-Piercy C. et al. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol 1999; 141 (1): 71-81</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Каширская Е.Н. Атопический дерматит и беременность (Особенности клиники, гормонально-метаболической перестройки, тактика ведения беременных как первичная профилактика атопического дерматита у детей): Автореф. дис. . канд. мед. наук. Екатеринбург, 1998</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Кочергин Н.Г. Особенности кожной патологии при беременности. Рос журн кож и венерич болезней 2002; 1: 33-36</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hellerström S. Studies of Besnier’s prurigo (atopic dermatitis). S. Hellerström, H. Lidman. Acta Derm Venereol 1956; 36: 11-22</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Клиническая аллергология и иммунология. Руководство для практикующих врачей / под ред. Л.А. Горячкиной, К.П. Кашкина. М: Миклош 2011; 432</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Wojnarowska F. The skin in pregnancy. Oxford textbook of medicine: Fourth edition / ed. by D.A. Warell et al. Vol. 1. New York: Oxford Universisity Press, 2006.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Kaiser H.B., Gopalan G., Chung W. Loratadine provides early symptom control in seasonal allergic rhinitis. Allergy Asthma Proc 2008; 29 (6): 654-8.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Roman I.J., Kassem N., Gural R.P. et al. Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man. Ann Allergy 1986; 57: 253-6.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Kâllén B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med 2002; 11 (3): 146-52.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Moretti M.E., Caprara D., Coutinho C.J., Bar-Oz B., Berkovitch M., Addis A. et al. Fetal safety of loratadine use in the first trimester of preg nancy: a multicentre study. J Allergy Clin Immunol 2003; 111 (3): 479-83.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Diav-Citrin O., Shechtman S., Aharonovich A., Moerman L., Arnon J., Wajnberg R. et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled study. J Allergy Clin Immunol 2003; 111 (6): 1239-43.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Kallen B., Olausson P.O. Monitoring of maternal drug use and infant congenital malforma tions. Does loratadine cause hypospadias? Int J Risk Saf Med 2001; 14: 115-9.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>So M., Bozzo P., Inoue M., Einarson A. Safety of antihistamines during pregnancy and lactation. Canadian Family Physician. 2010; 56: 427-9.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Gilboa S.M., Strickland M.J., Olshan A.F., Werler M.M., Correa A., National Birth Defects Prevention Study. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol 2009; 85 (2): 137-50.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Schwarz E.B., Moretti M.E., Nayak S., Koren G. Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis. Drug Saf 2008; 31 (9): 775-88.</mixed-citation></ref></ref-list></back></article>
